Lifileucel: FDA-approved T-cell therapy for melanoma

被引:3
|
作者
Kwong, Mei Li M. [1 ]
Yang, James C. [1 ]
机构
[1] NCI, Surg Branch, NIH, Bethesda, MD 20814 USA
来源
ONCOLOGIST | 2024年 / 29卷 / 08期
关键词
TUMOR-INFILTRATING LYMPHOCYTES; METASTATIC MELANOMA; ADOPTIVE TRANSFER; IMMUNOTHERAPY; INTERLEUKIN-2; EFFICACY; CANCER;
D O I
10.1093/oncolo/oyae136
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This commentary reports on the history of tumor-infiltrating lymphocytes (TIL) for adoptive cell therapy and where TIL fits into the treatment options for metastatic melanoma.
引用
收藏
页码:648 / 650
页数:3
相关论文
共 50 条
  • [21] Recent changes to FDA-approved labeling
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (05) : 418 - 418
  • [22] FDA-Approved Oligonucleotide Therapies in 2017
    Stein, Cy A.
    Castanotto, Daniela
    MOLECULAR THERAPY, 2017, 25 (05) : 1069 - 1075
  • [23] Analysis of FDA-approved imaging agents
    Kinch, Michael S.
    Woodard, Pamela K.
    DRUG DISCOVERY TODAY, 2017, 22 (07) : 1077 - 1083
  • [24] 2023 FDA-approved psychotropic medications
    Naguy, Ahmed
    Alayadhi, Nadyah
    Pridmore, Saxby
    Alhazeem, Hessa
    Alamiri, Bibi
    ASIAN JOURNAL OF PSYCHIATRY, 2023, 87
  • [25] Recent changes to FDA-approved labeling
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (21) : 2048 - +
  • [26] Recent changes to FDA-approved labeling
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (08) : 794 - 794
  • [27] An overview of FDA-approved biologics medicines
    Kinch, Michael S.
    DRUG DISCOVERY TODAY, 2015, 20 (04) : 393 - 398
  • [28] FDA-approved therapies for chronic GVHD
    Lee, Stephanie J.
    Zeiser, Robert
    BLOOD, 2025, 145 (08) : 795 - 800
  • [29] Usability of FDA-Approved Medication Guides
    Michael S. Wolf
    Jennifer King
    Elizabeth A. H. Wilson
    Laura M. Curtis
    Stacy Cooper Bailey
    James Duhig
    Allison Russell
    Ashley Bergeron
    Amanda Daly
    Ruth M. Parker
    Terry C. Davis
    William H. Shrank
    Bruce Lambert
    Journal of General Internal Medicine, 2012, 27 : 1714 - 1720
  • [30] Recent changes to FDA-approved labeling
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (03) : 232 - 232